(Q41073361)

English

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

scientific article published on 14 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study (English)

1 reference

Europe PubMed Central

26 September 2017

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Kai Chow Choi

2

0 references

Anthony Wing-Hung Chan

object named as

Anthony Wing-Hung Chan

8

0 references

Juliana Chung-ngor Chan

object named as

Juliana Chung-Ngor Chan

10

0 references

Grace Lai-Hung Wong

3

object named as

Grace Lai-Hung Wong

1 reference

Europe PubMed Central

26 September 2017

author name string

Raymond Kwok

1

1 reference

Europe PubMed Central

26 September 2017

Yuying Zhang

4

1 reference

Europe PubMed Central

26 September 2017

Henry Lik-Yuen Chan

5

1 reference

Europe PubMed Central

26 September 2017

Andrea On-Yan Luk

6

1 reference

Europe PubMed Central

26 September 2017

Sally She-Ting Shu

7

1 reference

Europe PubMed Central

26 September 2017

Ming-Wai Yeung

9

1 reference

Europe PubMed Central

26 September 2017

Alice Pik-Shan Kong

11

1 reference

Europe PubMed Central

26 September 2017

Vincent Wai-Sun Wong

12

1 reference

Europe PubMed Central

26 September 2017

language of work or name

0 references

publication date

14 April 2015

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

65

1 reference

Europe PubMed Central

26 September 2017

1359-1368

1 reference

Europe PubMed Central

26 September 2017

8

1 reference

Europe PubMed Central

26 September 2017

Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Transient elastography

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Monitoring the Targets of the St Vincent Declaration and the Implementation of Quality Management in Diabetes Care: the DiabCare Initiative

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309265

21 January 2018

Identifiers

10.1136/GUTJNL-2015-309265

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41073361&oldid=1914567353"